Monthly Archives: November 2012

When it Comes to Patients, There is No Average

average

Next month, the National Pharmaceutical Council will host a forum — which BIO is cosponsoring — that will focus on the unique differences among treatment effects in individual patients and how policymakers, payers, and providers could shape programs and policies to acknowledge those differences. The forum, “The Myth of Average:  Why Individual Patient Differences Matter” is taking place on November 30 at the Omni Shoreham Hotel in Washington, D.C. More information and registration materials are available Read More >

Events  |  Leave a comment  |  Email This Post

Academics to be Featured at the 2013 BIO Alliance Pavilion

BIO International Convention

I think it safe to say that the U.S. biotechnology industry has its R&D roots in the laboratories of great research universities with great science and visionary researchers. These cutting-edge, biology-based research and industry commercialization efforts continue to be the key drivers in moving invention into innovation to heal, fuel and feed the world. Because of this essential knowledge-driven relationship, the 2013 BIO International Convention will again bring together academic and research colleagues to focus Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Flight Flies on 100 Percent Biofuels

falcon-20

This week saw the first-ever completely biofuel-powered flight take place. The National Research Council of Canada conducted the first flight on 100 percent renewable, drop-in biofuel on its Falcon 20 jet, according to oilprice.com, marking a huge milestone for the aviation and renewable energy industries. Oilseed crops commercialized by Agrisoma were used as a feedstock and transformed by Applied Research Associates into a complete replacement fuel for conventional jet fuel. Previously, flights on biofuels had Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

SIPO Examiner Workshop: Biotech Patent Practices in the U.S., China and Japan

Great Wall of China - Image by jrover

The biotechnology industry is an invention-intensive industry that relies heavily on the protection of intellectual property, especially patent rights. Patent protection is territorial, and patent practice varies in different jurisdictions. Many foreign biotech companies continue to look at China as an important emerging market, and they increasingly file patent applications in China to develop their global patent portfolios. At the same time, China has made biotechnology one of the eight strategic new technology focuses in Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,